KDR and small cell lung carcinoma: The role of neoangiogenesis in SCLC is well-established, with the vascular endothelial growth factor (VEGF) and its receptor (VEGFR) as the central molecular axis involved (36–38); a higher serum concentration of VEGF correlates with poor survival (39).